MYC and brain neoplasm: These results are in line with the contribution of MYC signaling to H3-K27M-driven tumorigenesis (Pajovic et al., 2020; Dubois et al., 2022), underscoring the therapeutic potential of Sulfopin for these aggressive brain tumors.